Difference between revisions of "Combining-Topiramate-Gabapentin"
From Psychiatrienet
(Created page with '{{Drugcombi | base = topiramate | add = gabapentin | info = * Topiramate induces CYP3A4 and is an inhibiter of CYP2C19. * Gabapentine is eliminated unchanged by the kidney for ...') |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 3: | Line 3: | ||
| add = gabapentin | | add = gabapentin | ||
| info = | | info = | ||
| − | |||
| − | |||
* This combination of drugs may have possible synergistic effects. There are no reports for pharmacokinetic drug interactions. However, the combination will have additional side effects. | * This combination of drugs may have possible synergistic effects. There are no reports for pharmacokinetic drug interactions. However, the combination will have additional side effects. | ||
| start = | | start = | ||
| − | * Start | + | * Start gabapentin according to the general dosing advice. |
| cave = | | cave = | ||
}} | }} | ||
Latest revision as of 15:52, 21 April 2010
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
Adding gabapentin to topiramate.
General information- Topiramate induces CYP3A4 and is an inhibitor of CYP2C19.
- Gabapentin is eliminated unchanged by the kidney for 100%.
- This combination of drugs may have possible synergistic effects. There are no reports for pharmacokinetic drug interactions. However, the combination will have additional side effects.
Start gabapentin- Start gabapentin according to the general dosing advice.
- ↑ 1.0 1.1 1.2 Farmacotherapeutisch Kompas - topiramaat (dutch)
Cite error: Invalid
<ref>tag; name "ftk" defined multiple times with different content
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
